SABBY MANAGEMENT, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Oragenics Inc 13G
OGEN · 684023609
9.9% 1/21/2026
Event 12/31/2025
Tempest Therapeutics, Inc. 13G
TPST · 87978U207
9.9% 1/21/2026
Event 12/31/2025
Jiuzi Holdings, Inc. 13G/A Amendment 1
JZXN · G51400151
9.9% 1/21/2026
Event 12/31/2025
Globavend Holdings Ltd 13G
GVH · G3R39B116
9.9% 1/21/2026
Event 12/31/2025
Foxo Technologies Inc. 13G
FOXO · 351471503
9.9% 1/21/2026
Event 12/31/2025
Revelation Biosciences, Inc. 13G
REVB · 76135L705
9.6% 1/20/2026
Event 12/31/2025
Nuwellis, Inc. 13G
NUWE · 67113Y702
5.4% 1/20/2026
Event 12/31/2025
Lyra Therapeutics, Inc. 13G
LYRA · 55234L204
9.9% 1/20/2026
Event 12/31/2025
Jiuzi Holdings, Inc. 13G
JZXN · G51400151
9.9% 1/20/2026
Event 12/31/2025
InMed Pharmaceuticals Inc. 13G
INM · 457637700
9.9% 1/20/2026
Event 12/31/2025
Biodexa Pharmaceuticals Plc 13G
BDRX · 59564R880
9.9% 1/20/2026
Event 12/31/2025
Big Tree Cloud Holdings Ltd 13G
DSY · G1263B108
6.6% 1/20/2026
Event 12/31/2025
Universe Pharmaceuticals INC 13G/A Amendment 1
UPC · G9442G138
4.9% 1/7/2026
Event 12/31/2025
Empery Digital Inc. 13G/A Amendment 1
EMPD · 92864V608
1.3% 1/7/2026
Event 12/31/2025
BNB Plus Corp. 13G/A Amendment 1
BNBX · 03815U607
4.9% 1/7/2026
Event 12/31/2025
Transcode Therapeutics, Inc. 13G/A Amendment 1
RNAZ · 89357L501
4.9% 1/7/2026
Event 12/31/2025
Cyngn Inc. 13G/A Amendment 2
CYN · 23257B305
1.0% 1/7/2026
Event 12/31/2025
Universe Pharmaceuticals INC 13G
UPC · G9442G104
9.9% 1/3/2025
Event 12/31/2024
Volcon, Inc. 13G
VLCN · 92864V509
9.9% 1/3/2025
Event 12/31/2024
Applied Dna Sciences Inc 13G
APDN · 03815U409
10.0% 1/3/2025
Event 12/31/2024
Transcode Therapeutics, Inc. 13G
RNAZ · 89357L402
9.9% 1/3/2025
Event 12/31/2024
Scinai Immunotherapeutics Ltd. 13G
BVXV · 09073Q105
4.9% 1/3/2025
Event 12/31/2024
Cyngn Inc. 13G/A Amendment 1
CYN · 23257B107
9.9% 1/3/2025
Event 12/31/2024
Phunware, Inc. 13G/A Amendment 1
PHUN · 71948P100
0% 1/3/2025
Event 12/31/2024
iBio, Inc. 13G/A Amendment 1
IBIO · 451033203
0.2% 1/3/2025
Event 12/31/2024
Treasure Global Inc 13G/A Amendment 1
TGA · 893662106
0% 1/3/2025
Event 12/31/2024
InMed Pharmaceuticals Inc. 13G/A Amendment 1
INM · 457637502
4.9% 1/3/2025
Event 12/31/2024
Lipella Pharmaceuticals Inc. 13G/A Amendment 1
LIPO · 53630L100
4.9% 1/3/2025
Event 12/31/2024
Bluejay Diagnostics, Inc. 13G/A Amendment 1
BJDX · 095633103
4.9% 1/3/2025
Event 12/31/2024
Tonix Pharmaceuticals Holding Corp. 13G/A Amendment 1
TNXP · 890260854
0.7% 1/3/2025
Event 12/31/2024
Fangdd Network Group Ltd. 13G/A Amendment 1
DUO · 30712L109
4.9% 1/3/2025
Event 12/31/2024
Glucotrack, Inc. 13G/A Amendment 1
GCTK · 45824Q507
4.9% 1/3/2025
Event 12/31/2024
Recon Technology, Ltd 13G/A Amendment 1
RCON · G7415M124
0% 1/3/2025
Event 12/31/2024
Arcadia Biosciences, Inc. 13G/A Amendment 1
RKDA · 039014204
4.9% 1/3/2025
Event 12/31/2024
Mobiquity Technologies, Inc. 13G/A Amendment 1
MOBQ · 60743F508
0% 1/2/2025
Event 12/31/2024
Revelation Biosciences, Inc. 13G/A Amendment 1
REVB · 76135L101
4.9% 1/2/2025
Event 12/31/2024
TuanChe Ltd 13G/A Amendment 1
TC · 89856T104
5.0%
Checked 5% or less
1/2/2025
Event 12/31/2024